HealthTech in Asiaabout 5 hours ago
AstraZeneca signs $1.5b AI drug deal
5 min read
AstraZeneca partners with biotech firm Insitro on October 15 for a $1.5 billion AI drug discovery deal targeting liver and heart diseases. The agreement includes $40 million upfront plus up to $1.46 billion in milestone payments contingent on research progress and future sales royalties.
Level
Hype check
Tap to vote and see what everyone thinks.
